“…In addition, we identified in 43.2% VUS, which could become clinically relevant in the future. This rate supports other studies focusing on the genetic diagnosis of AID [5,13,[36][37][38][39][40][41]. Cohorts of equal size [5,13,36] and larger cohorts [41] were both evaluated in these studies, and some only included pediatric patients [12,39,42,43], while others also included adults [36-38, 41, 44, 45].…”